33 results on '"Citterio, F"'
Search Results
2. Immunosuppression with Belatacept-Based, Corticosteroid-Avoiding Regimens in De Novo Kidney Transplant Recipients
3. Pharmacokinetics for Once- Versus Twice-Daily Tacrolimus Formulations in De Novo Kidney Transplantation: A Randomized, Open-Label Trial
4. Long-Term Clinical Impact of Vesicoureteral Reflux in Kidney Transplantation
5. Cardiovascular Risk Profile in Kidney Transplant Recipients Treated With Two Immunosuppressive Regimens: Tacrolimus and Mycophenolate Mofetil Versus Everolimus and Low-Dose Cyclosporine
6. Prospective Clinical Trial Comparing Two Immunosuppressive Regimens, Tacrolimus and Mycophenolate Mofetil Versus Everolimus and Low-Dose Cyclosporine, in De Novo Renal Transplant Recipients: Results at 6 Months Follow-up
7. Risk of Kaposi Sarcoma after Solid-Organ Transplantation: Multicenter Study in 4767 Recipients in Italy, 1970–2006
8. Results of an International, Randomized Trial Comparing Glucose Metabolism Disorders and Outcome with Cyclosporine Versus Tacrolimus
9. Higher Incidence of Acute Rejection in Renal Transplant Recipients With Low Everolimus Exposure
10. Incidence of Posttransplant Diabetes Mellitus in Kidney Transplant Recipients Immunosuppressed With Sirolimus in Combination With Cyclosporine
11. Abdominal Aortic Aneurysm in Renal Transplant Recipients
12. Comparison of Oblique Versus Hockey-Stick Surgical Incision for Kidney Transplantation
13. Gonadal Function and Immunosuppressive Therapy After Renal Transplantation
14. Severe Limb Lymphedema in Sirolimus-Treated Patients
15. Addition of Sirolimus to Cyclosporine in Long-Term Kidney Transplant Recipients to Withdraw Steroid
16. Evolution of the therapeutic drug monitoring of cyclosporine
17. C2 is an age-independent parameter for optimal cyclosporine exposure in long-term kidney transplant recipients
18. Long-Term predictive value of cyclosporine microemulsion C 2 level for chronic renal allograft dysfunction
19. Effects of immunosuppressive regimens on plasma levels of transforming growth factor-beta 1 in renal transplant recipients
20. C2 single-point sampling to evaluate cyclosporine exposure in long-term renal transplant recipients
21. Lymphocele After Renal Transplantation: The Influence of the Immunosuppressive Therapy
22. Plasma levels of transforming growth factor-β1 in renal transplant recipients receiving different immunosuppressive regimens
23. Posttransplant diabetes mellitus after kidney transplantation with different immunosuppressive agents
24. Design of a trial comparing sirolimus plus mycophenolate mofetil versus sirolimus plus cyclosporine
25. Steroid withdrawal from tacrolimus-based therapy in renal transplant patients
26. Conversion to tacrolimus immunosuppression in renal transplant recipients: 12-month follow-up
27. Acute rejection after renal transplantation with tacrolimus-based therapy in conditions of normal clinical practice
28. Renal vein thrombosis after renal transplantation: an important cause of graft loss
29. Lack of correlation between serum levels of mycophenolate mofetil and kidney transplant outcome in tacrolimus-based immunosupression
30. Azithromycin treatment of gingival hyperplasia in kidney transplant recipients is effective and safe
31. Risk of myocardial infarction and angina in patients with severe peripheral vascular disease. Predictive role of C-reactive protein
32. Preface
33. Different thrombotic and inflammatory patterns between unstable angina and peripheral vascular disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.